ArticleScientific reports2023

In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.

Marta Gómara-Lomero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.